Nifty added half a percent and advancers beat decliners nearly two to one, the best breadth ratio in a month. Look one layer down and the picture inverts: the share of stocks in a genuine Stage-2 advance fell to 30.75%, the lowest reading in 30 sessions, and the five-day tally of stocks stepping down from advancing to topping has never been this lopsided in the window. This is a bounce inside a market that is still quietly de-risking underneath.
Good day, bad trend
Today's advance-decline ratio of 1.97 is the strongest of the last 30 sessions, better even than the pre-selloff highs in August. But the net five-day transition count, stocks moving up a stage minus stocks moving down a stage, sits at minus 48, the worst of the window, and it has been negative for 20 straight sessions. Golden crosses have shrunk to just four names, tying the low for the period, while death crosses at five now outnumber them. The regime label itself has sat in a neutral-to-down read for sixteen sessions running. Read together, today's bounce looks like relief within a downtrend, not a change of trend. Breadth days like this can mark a low, but one session doesn't undo three weeks of deteriorating structure.
Energy is the one sector actually building
Away from the index, Energy stands out: its Stage-2 share has jumped over twenty points in the past month to 55%, easily the highest of any sector, led by Oil & Gas equipment and services names running hard on both one-month and three-month returns. Materials and Health Care are also holding up on relative strength. Information Technology is the opposite story, the only sector red today, down over five percent on the month, and its Stage-2 share has been shrinking for weeks alongside Financials and Industrials, both of which have lost more than six points of Stage-2 share in twenty sessions. Real Estate has faded fast too. The rotation is narrow, not broad, and that lines up with the breadth-versus-trend split above.
What to do with the setups list
The early-stage names worth watching without having missed the move include Maharashtra Seamless and Ratnamani Metals from Industrials, Alembic from Health Care, and Hindustan Oil Exploration, all still close to their 50-day average rather than extended. The sustained list, led by Bhageria Industries, Raymond and Oriental Aromatics, shows where the strongest trends already are, useful as a read on leadership, not as a buy list, since those moves are the most stretched. Given the Stage-2 count is at a fresh low for the period and transitions keep going the wrong way, this is a day to be selective about entries rather than chase the green print.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Maharashtra Seamless Ltd | Industrials | 7.9 | +0.8% |
| Alembic Ltd | Health Care | 7.9 | +1.2% |
| Hindustan Oil Exploration Company Ltd | Energy | 7.5 | -0.7% |
| Venky's (India) Ltd | Consumer Staples | 7.5 | +1.0% |
| SoftTech Engineers Ltd | Information Technology | 7.4 | -1.3% |
| Hatsun Agro Product Ltd | Consumer Staples | 7.4 | -1.1% |
| Ratnamani Metals and Tubes Ltd | Industrials | 7.4 | +0.7% |
| Godrej Agrovet Ltd | Consumer Staples | 7.3 | +2.5% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Consumer Staples | +1.4% | -2.3% | -3.0% | 47 | 33% |
| Materials | +1.4% | -1.1% | +2.5% | 64 | 36% |
| Real Estate | +1.3% | -3.1% | +7.9% | 54 | 20% |
| Health Care | +1.0% | +3.5% | +9.9% | 73 | 48% |
| Financials | +0.9% | -2.1% | -2.2% | 58 | 29% |
| Industrials | +0.7% | -0.7% | +0.1% | 66 | 26% |
| Communication Services | +0.6% | -1.1% | +7.7% | 60 | 22% |
| Energy | +0.5% | -2.7% | -2.1% | 56 | 55% |
| Consumer Discretionary | +0.3% | -2.1% | +7.4% | 59 | 33% |
| Utilities | +0.3% | -2.0% | -8.6% | 56 | 15% |
| Information Technology | -0.6% | -5.3% | +2.4% | 42 | 22% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.